EuroMedtech EBD Group EuroMedtech

Thank you for participating in EuroMedtech™ 2014

Follow up, research and set notifications with watchlist > partnering360®
Download reports, stats and review your agenda > partneringONE®

EuroMedtech™ 2014 in numbers
  • 265 attendees
  • 749 one-to-one meetings
  • 124 licensing opportunities posted
  • 183 companies
  • 27 company presentations
  • 12 exhibitors
  • 21 countries represented
  • 10 workshops and panels

View impressions of EuroMedtech ►
See videos of EuroMedtech ►

Save the date and check back in the coming weeks for information on next year's EuroMedtech.

more ►

Conference videos

Interview: Luc Tissot, Tissot Medical Research SA Interview: Luc Tissot, Tissot Medical Research SAMay 8, 2014 | EuroMedtech™ 2014Luc Tissot of Tissot Medical Research SA discusses their technology to measure the eye pressure that causes glaucoma, and their interest in commercialization partners. View session here View session here
Interview: Michael Alper, NeuvoMedica Interview: Michael Alper, NeuvoMedicaMay 8, 2014 | EuroMedtech™ 2014Michael Alper, Managing Director of NeuvoMedica, discusses the benefits and challenges of doing business in China. View session here View session here
Interview:  Dr. Mark Charny, Translucency Interview: Dr. Mark Charny, TranslucencyMay 7, 2014 | EuroMedtech™ 2014Mark Charny of Translucency, a UK-based consultancy, advises companies to start preparing for where they want to launch their products as early as possible. View session here View session here
Interview: Martin Penver, LRQA Interview: Martin Penver, LRQA May 7, 2014 | EuroMedtech™ 2014Ashley Yeo interviews Martin Penver of Lloyd’s Register Quality Assurance (LRQA) about the timetable for medical device regulation in the EU. View session here View session here
Interview: Stéphane Lepretre, Eurasante Interview: Stéphane Lepretre, EurasanteMay 7, 2014 | EuroMedtech™ 2014Stéphane Lepretre explains Eurasante’s role as an incubator working to promote technology transfer, especially to companies looking to open a facility in the North of France. View session here View session here
Interview: Helen Montag, Johns Hopkins Interview: Helen Montag, Johns HopkinsMay 7, 2014 | EuroMedtech™ 2014Tina Tan interviews Helen Montag of Johns Hopkins University, who works with individual academics to determine which translational projects are ready to partner. View session here View session here
Financing instruments for a market under pressure Financing instruments for a market under pressureMay 8, 2014 | EuroMedtech™ 2014The upheaval in financial markets since 2008 caused the emergence of innovative new ways of financing to match the technologies developed to meet the needs of healthcare systems. View session here View session here
A  new source of buying power: The trend of outward investment from China A new source of buying power: The trend of outward investment from ChinaMay 8, 2014 | EuroMedtech™ 2014The Chinese medtech market is developing rapidly. International companies are looking at China for new market entry, and Chinese companies are looking outside the domestic market. View session here View session here
Pharma friend or foe: Blurring the border between drug and device treatments Pharma friend or foe: Blurring the border between drug and device treatmentsMay 7, 2014 | EuroMedtech™ 2014There is increasing use of devices where drugs used to be the only treatment. Does this mean medtech and pharma will compete in the same markets, or form new partnerships? View session here View session here
The MDR bottom line: What will the new European Medical Device Regulation cost your firm? The MDR bottom line: What will the new European Medical Device Regulation cost your firm?May 7, 2014 | EuroMedtech™ 2014Medical device policy in Europe is being watched closely by companies and regulatory bodies. Major changes to be implemented this year could have wide ranging effects on the industry. View session here View session here
Collaborating with payers: New patterns of engagement Collaborating with payers: New patterns of engagementMay 7, 2014 | EuroMedtech™ 2014As healthcare systems struggle to manage older populations with chronic illnesses, insurers are engaging in new ways with companies who develop tools to manage these conditions. View session here View session here
Balancing improved healthcare technology and cost through innovative approaches to medical device development Balancing improved healthcare technology and cost through innovative approaches to medical device developmentMay 7, 2014 | EuroMedtech™ 2014The demand to provide better healthcare at lower cost a driving force in product development and is critical to attracting investment in emerging medical device companies. View session here View session here
Interview with Sigal Weisswasser, The T.B.N. Group Interview with Sigal Weisswasser, The T.B.N. GroupMarch 11, 2014 | EuroMedtech™ 2014Sigal Weißwasser of The T.B.N. Group shares her approach to creating business acceleration strategies that span international boundaries in this interview ahead of EuroMedtech in May 2014. View session here View session here
Interview with Matthias Krings, Catenion Interview with Matthias Krings, CatenionMarch 11, 2014 | EuroMedtech™ 2014Dr. Matthias Krings, Senior Partner at Catenion, speaks on challenges faced by medtech and some recent collaborations. Meet Krings in person at EuroMedtech 2014 in Linz this May. View session here View session here
Interview with Christian Haller Interview with Christian HallerJanuary 15, 2014 | EuroMedtech™ 2014Christian L. Haller, President of RavenOye Group, discusses his company’s focus and services including strategic planning, and procuring access to experienced experts in marketing, regulation and payer groups. View session here View session here
Interview with Vicki Anastasi Interview with Vicki AnastasiJanuary 15, 2014 | EuroMedtech™ 2014Vicki Anastasi, Senior VP of Aptiv Solutions, discusses hurdles facing the medtech sector and the future of financing medical devices. View session here View session here
Interview with Regina Hodits Interview with Regina HoditsJanuary 15, 2014 | EuroMedtech™ 2014Regina Hodits of Wellington Partners discusses her approach to medtech investing and how she is finding novel technologies in the US to be funded in Europe. View session here View session here
Interview with Rainer Strohmenger Interview with Rainer StrohmengerJanuary 15, 2014 | EuroMedtech™ 2014Rainer Strohmenger, Wellington Partners, discusses his firm's investment criteria and outlook for the medtech industry. View session here View session here
New kids on the block? The role of patients in eHealth tool development New kids on the block? The role of patients in eHealth tool developmentMay 8, 2013 | EuroMedtech™ 2013One means of monetizing eHealth products is the consumer pathway: creating tools that patients use to diagnose, monitor, and maintain their health, tools that they will pay for. View session here View session here
From the trenches: Entrepreneur war stories From the trenches: Entrepreneur war storiesMay 8, 2013 | EuroMedtech™ 2013Join a group of serial medtech entrepreneurs as they discuss the challenges, failures, successes and rewards of creating companies around medtech innovations. View session here View session here
Navigating the maze: Regulatory changes in Europe Navigating the maze: Regulatory changes in EuropeMay 8, 2013 | EuroMedtech™ 2013The regulatory changes in the EU are creating a shifting landscape for SMEs and large companies alike. How will these affect product development in years to come? View session here View session here
Joining forces: Exploring point-of-care collaborations Joining forces: Exploring point-of-care collaborationsMay 7, 2013 | EuroMedtech™ 2013The development of increasingly sophisticated POC diagnostics has involved increasing levels of collaboration among companies to achieve faster, more accurate POC results. View session here View session here
Inside innovation: How developments in financing, strategy and collaboration are driving the medtech machine Inside innovation: How developments in financing, strategy and collaboration are driving the medtech machineMay 7, 2013 | EuroMedtech™ 2013What big innovations, in products, business models, financing and partnering, are responsible for the relative health of the medtech powerhouse? View session here View session here
Spotlight on...operating in the China market Spotlight on...operating in the China marketMay 7, 2013 | EuroMedtech™ 2013This panel explores the commercial landscape of medical devices in China, and the benefits, challenges and networks that Western companies should know to operate successfully. View session here View session here



About the conference

EuroMedtech™ 2013 Highlights

  • 261 attendees
  • 600 one-to-one meetings
  • 68 licensing opportunities posted
  • 191 companies
  • 44 company presentations
  • 12 exhibitors
  • 22 countries represented
  • 8 workshops and panels

Photos of EuroMedtech 2013 ►


Videos from EuroMedtech ►

Dealmaking for the Medtech Industry

EuroMedtech™ is Europe's leading medical technology partnering conference, providing collaboration opportunities to medtech decision makers and investors. EuroMedtech caters to companies involved in all parts of the advanced medical technology industry, from those serving mainline therapeutic categories such as orthopedics and cardiovascular, through diagnostics, imaging and eHealth to those involved in platform technologies such as biomaterials and regenerative medicine. Also attending are companies serving the industry, such as manufacturers, law firms, CROs and distributors.

Featuring EBD Group's sophisticated, web-based partnering system, partneringONE®, the event enables delegates to efficiently identify, meet and do business with attending companies, from large international medtech companies and just launched start-ups, to venture capitalists and private equity firms.



more ►

Company presentations

Acarix A/S
Thursday, 10:10 | Ground Level | Room 1
AFreeze
Wednesday, 15:30 | Ground Level | Room 1
Avalon Health Economics
Wednesday, 12:30 | Ground Level | Room 2
AventaMed
Wednesday, 12:00 | Ground Level | Room 1
Carthera SAS
Wednesday, 12:50 | Ground Level | Room 1
CiToxLAB Scantox
Wednesday, 12:40 | Ground Level | Room 2
ConsulTech GmbH
Thursday, 10:20 | Ground Level | Room 1
CVTec Cerebrovascular Technologies GmbH
Wednesday, 12:40 | Ground Level | Room 1
Emperra GmbH
Wednesday, 12:30 | Ground Level | Room 1
GNA Biosolutions GmbH
Wednesday, 16:20 | Ground Level | Room 1
Humedics GmbH
Thursday, 10:30 | Ground Level | Room 1
Implandata Ophthalmic Products GmbH
Wednesday, 12:10 | Ground Level | Room 1
ImPress MedTech e.U.
Thursday, 11:10 | Ground Level | Room 1
Inventram/Tarabios
Thursday, 10:50 | Ground Level | Room 1
iSTAR Medical SA
Wednesday, 12:20 | Ground Level | Room 1
J A Kemp
Wednesday, 12:00 | Ground Level | Room 2
Johns Hopkins University
Wednesday, 12:50 | Ground Level | Room 2
LevOss
Wednesday, 16:10 | Ground Level | Room 1
LIVEcheck Global Diagnostics
Thursday, 11:00 | Ground Level | Room 1
Michelson Diagnostics Ltd
Wednesday, 16:30 | Ground Level | Room 1
Miracor Medical Systems GmbH
Wednesday, 15:50 | Ground Level | Room 1
Sagentia
Wednesday, 12:10 | Ground Level | Room 2
Senzime
Thursday, 10:40 | Ground Level | Room 1
Sheltagen Medical Ltd
Wednesday, 16:00 | Ground Level | Room 1
Software Quality Lab GmbH
Wednesday, 12:20 | Ground Level | Room 2
Tissot Medical Research SA
Wednesday, 16:40 | Ground Level | Room 1
Transcatheter Technologies GmbH
Wednesday, 15:40 | Ground Level | Room 1
more ►

#EMT14 on Twitter



Who will you meet?

Executives from:
  • Emerging medical technology companies
  • Established large medtech companies
  • Venture capital, private equity and institutional financial firms
  • Distributors and hospitals
  • Service related companies

Breakdown of registrants and participating companies at EuroMedtech
click to enlarge

EuroMedtech features

One-to-one partnering meetings
One-to-one partnering meetings
State-of-the-art partnering software enables participants to identify and select the most suitable potential partners. The system—industry-specific, web-based and interactive—is uniquely suited for the needs of medical technology companies. more

Sessions
Sessions
High level faculty serve on panels and workshops, in which industry experts provide updated analyses and share their experience with the audience. more

Company presentations
Company presentations
Selected medical technology companies present their products, technologies and corporate missions in 14-minute presentations. In addition young innovative start-ups present in 7-minute "Next Generation" sessions. more

Exhibition
Exhibition
A lively exhibition in the heart of the conference area showcases companies, services and technologies. more

Arrow Up


 
 
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2014 EBD GmbH
Privacy Policy
Terms of Use
EuroMedtech EBD Group EuroMedtech